Reversal of cholecystokinin-induced persistent stimulation of pancreatic enzyme secretion by dibutyryl cyclic GMP

Am J Physiol. 1981 Jun;240(6):G466-71. doi: 10.1152/ajpgi.1981.240.6.G466.

Abstract

When pancreatic acini are first incubated with cholecystokinin, washed to remove free cholecystokinin, and then reincubated in fresh incubation solution, there is a significant residual stimulation of amylase secretion. Butyryl derivatives of cyclic GMP can prevent as well as reverse this cholecystokinin-induced residual stimulation. At 37 degrees C the nucleotide-induced reversal is complete within a few minutes, but at 4 degrees C complete reversal requires 90 min of incubation. The ability of butyryl cyclic GMP to reverse cholecystokinin-induced residual stimulation is itself fully reversible, and the nucleotide-induced reversal is accompanied by restoration of full responsiveness to cholecystokinin. The ability of dibutyryl cyclic GMP to reverse cholecystokinin-induced residual stimulation appears to result from the ability of the nucleotide to displace cholecystokinin from its receptors in pancreatic acini.

MeSH terms

  • Amylases / metabolism*
  • Animals
  • Atropine / pharmacology
  • Cholecystokinin / analogs & derivatives*
  • Cholecystokinin / pharmacology
  • Cyclic GMP / analogs & derivatives*
  • Dibutyryl Cyclic GMP / pharmacology*
  • Drug Antagonism
  • Guinea Pigs
  • Kinetics
  • Male
  • Pancreas / drug effects
  • Pancreas / enzymology*
  • Sincalide

Substances

  • Dibutyryl Cyclic GMP
  • Atropine
  • Cholecystokinin
  • Amylases
  • Cyclic GMP
  • Sincalide